Targeting cancer neoantigens: A promising source of immunogens for cancer immunotherapy

Targeting cancer neoantigens: A promising source of immunogens for cancer immunotherapy

Dr. Philip Arlen to Speak at World Vaccine Congress Europe

Topic: Targeting cancer neoantigens: A promising source of immunogens for cancer immunotherapy
10 – 12 October 2017,
Crowne Plaza Hotel Barcelona –
Fira Center, Barcelona

Share this post